Lördag 30 Augusti | 03:16:43 Europe / Stockholm

Kalender

Est. tid*
2026-02-19 18:00 Bokslutskommuniké 2025
2025-11-13 07:00 Kvartalsrapport 2025-Q3
2025-08-14 - Kvartalsrapport 2025-Q2
2025-05-08 - Kvartalsrapport 2025-Q1
2025-03-28 - X-dag ordinarie utdelning ZEAL 0.00 DKK
2025-03-27 - Årsstämma
2025-02-20 - Bokslutskommuniké 2024
2024-11-07 - Kvartalsrapport 2024-Q3
2024-08-15 - Kvartalsrapport 2024-Q2
2024-05-16 - Kvartalsrapport 2024-Q1
2024-03-21 - X-dag ordinarie utdelning ZEAL 0.00 DKK
2024-03-20 - Årsstämma
2024-02-27 - Bokslutskommuniké 2023
2023-11-09 - Kvartalsrapport 2023-Q3
2023-08-17 - Kvartalsrapport 2023-Q2
2023-05-11 - Kvartalsrapport 2023-Q1
2023-03-30 - X-dag ordinarie utdelning ZEAL 0.00 DKK
2023-03-29 - Årsstämma
2023-03-02 - Bokslutskommuniké 2022
2022-11-10 - Kvartalsrapport 2022-Q3
2022-08-11 - Kvartalsrapport 2022-Q2
2022-05-12 - Kvartalsrapport 2022-Q1
2022-05-09 - X-dag ordinarie utdelning ZEAL 0.00 DKK
2022-04-06 - Årsstämma
2022-03-10 - Bokslutskommuniké 2021
2021-11-11 - Kvartalsrapport 2021-Q3
2021-08-12 - Kvartalsrapport 2021-Q2
2021-05-12 - Kvartalsrapport 2021-Q1
2021-04-16 - X-dag ordinarie utdelning ZEAL 0.00 DKK
2021-04-15 - Årsstämma
2021-03-11 - Bokslutskommuniké 2020
2020-11-12 - Kvartalsrapport 2020-Q3
2020-08-13 - Kvartalsrapport 2020-Q2
2020-05-14 - Kvartalsrapport 2020-Q1
2020-04-03 - X-dag ordinarie utdelning ZEAL 0.00 DKK
2020-04-02 - Årsstämma
2020-03-12 - Bokslutskommuniké 2019
2019-11-14 - Kvartalsrapport 2019-Q3
2019-08-15 - Kvartalsrapport 2019-Q2
2019-05-16 - Kvartalsrapport 2019-Q1
2019-04-05 - X-dag ordinarie utdelning ZEAL 0.00 DKK
2019-04-04 - Årsstämma
2019-03-07 - Bokslutskommuniké 2018
2018-11-15 - Kvartalsrapport 2018-Q3
2018-08-16 - Kvartalsrapport 2018-Q2
2018-05-16 - Kvartalsrapport 2018-Q1
2018-04-20 - X-dag ordinarie utdelning ZEAL 0.00 DKK
2018-04-19 - Årsstämma
2018-03-07 - Bokslutskommuniké 2017
2017-11-08 - Kvartalsrapport 2017-Q3
2017-08-24 - Kvartalsrapport 2017-Q2
2017-05-17 - Kvartalsrapport 2017-Q1
2017-04-06 - X-dag ordinarie utdelning ZEAL 0.00 DKK
2017-04-05 - Årsstämma
2017-03-15 - Bokslutskommuniké 2016
2016-11-09 - Kvartalsrapport 2016-Q3
2016-08-25 - Kvartalsrapport 2016-Q2
2016-05-18 - Kvartalsrapport 2016-Q1
2016-04-20 - X-dag ordinarie utdelning ZEAL 0.00 DKK
2016-04-19 - Årsstämma
2016-03-16 - Bokslutskommuniké 2015
2015-11-05 - Kvartalsrapport 2015-Q3
2015-08-28 - Kvartalsrapport 2015-Q2
2015-05-22 - Kvartalsrapport 2015-Q1
2015-04-22 - X-dag ordinarie utdelning ZEAL 0.00 DKK
2015-04-21 - Årsstämma
2015-03-12 - Bokslutskommuniké 2014
2014-11-07 - Kvartalsrapport 2014-Q3
2014-08-21 - Kvartalsrapport 2014-Q2
2014-05-06 - Kapitalmarknadsdag 2014
2014-04-29 - Årsstämma
2014-04-29 - Kvartalsrapport 2014-Q1
2014-03-21 - X-dag ordinarie utdelning ZEAL 0.00 DKK
2014-03-20 - Bokslutskommuniké 2013
2013-11-15 - Kvartalsrapport 2013-Q3
2013-08-29 - Kvartalsrapport 2013-Q2
2013-05-15 - Kvartalsrapport 2013-Q1
2013-04-30 - X-dag ordinarie utdelning ZEAL 0.00 DKK
2013-04-30 - Årsstämma
2013-03-14 - Bokslutskommuniké 2012
2012-11-29 - Kapitalmarknadsdag 2012
2012-04-26 - X-dag ordinarie utdelning ZEAL 0.00 DKK
2012-04-25 - Årsstämma
2011-11-17 - Kvartalsrapport 2011-Q3
2011-10-25 - Kapitalmarknadsdag 2011
2011-08-18 - Kvartalsrapport 2011-Q2
2011-05-12 - Kvartalsrapport 2011-Q1
2011-04-29 - X-dag ordinarie utdelning ZEAL 0.00 DKK
2011-04-28 - Årsstämma

Beskrivning

LandDanmark
ListaLarge Cap Copenhagen
SektorHälsovård
IndustriBioteknik
Zealand Pharma är verksamt inom bioteknik. Särskilt fokus återfinns inom utvecklingen av läkemedel för behandling av diabetes och diverse tarmsjukdomar. Bolaget innehar en varierad produktportfölj med separata varumärken som säljs på global nivå. Störst verksamhet finns inom den nordiska marknaden. Zealand Pharma grundades 1997 och har sitt huvudkontor i Söborg, Danmark.
2025-08-28 17:00:00

Press release – No. 12 / 2025

Zealand Pharma to participate in upcoming investor conferences in September 2025

Copenhagen, Denmark, August 28, 2025 - Zealand Pharma A/S (Nasdaq: ZEAL) (CVR-no. 20045078), a biotechnology company focused on the discovery and development of innovative peptide-based medicines, today announced that the company will participate in the following investor conferences in September 2025.

  • Jefferies Swiss Healthcare Summit 2025, September 3 in Zürich

Adam Lange, Vice President, Investor Relations, will host investor meetings on Wednesday, September 3.

  • Cantor Global Healthcare Conference 2025, September 3-5 in New York

Adam Steensberg, President and Chief Executive Officer will host investor meetings on Thursday, September 4 and participate in a fireside chat at 8:00am EDT (14:00pm CET).

A live audio webcast of the fireside chat will be available at https://sqps.onstreamsecure.com/origin/enliven/players/EnlivenPlayer.html?customerId=22&eventId=18684721&checkCompany=1&checkEmail=1&checkName=1. A replay of the webcast will be available at https://www.zealandpharma.com/events/.

  • 2025 Wells Fargo Healthcare Conference, September 3-5 in Boston

Adam Steensberg, President and Chief Executive Officer will host investor meetings on Friday, September 5 and participate in a fireside chat at 8:45am EDT (14:45pm CET). The fireside chat will not be webcast.

  • Morgan Stanley Annual Healthcare Conference, September 8-10 in New York

Adam Lange, Vice President, Investor Relations, will host investor meetings on Wednesday, September 10.

  • Bank of America Global Healthcare Conference, September 23-25 in London

David Kendall, Executive Vice President and Chief Medical Officer will host investor meetings on Wednesday, September 24, and Thursday, September 25, and give a presentation at 10:45am UKT (11:45am CET) on Thursday, September 25.

A link to the audio webcast of the presentation will be available at https://www.zealandpharma.com/events/ in the coming weeks, where replays of all webcasts are also archived.

  • KBC Securities Life Sciences Conference, September 25 in Brussels

Adam Lange, Vice President, Investor Relations, will host investor meetings on Thursday, September 25.

About Zealand Pharma
Zealand Pharma A/S (Nasdaq: ZEAL) is a biotechnology company focused on the discovery and development of peptide-based medicines. More than 10 drug candidates invented by Zealand Pharma have advanced into clinical development, of which two have reached the market and three candidates are in late-stage development. The company has development partnerships with a number of pharma companies as well as commercial partnerships for its marketed products.
Zealand Pharma was founded in 1998 and is headquartered in Copenhagen, Denmark, with a presence in the U.S. For more information about Zealand Pharma’s business and activities, please visit www.zealandpharma.com.

Contacts
Adam Lange (Investors)
Vice President, Investor Relations
Zealand Pharma
Email: alange@zealandpharma.com

Neshat Anis Ahmadi (Investors)
Investor Relations Manager
Zealand Pharma
Email: neahmadi@zealandpharma.com

Anna Krassowska, PhD (Investors and Media)
Vice President, Investor Relations & Corporate Communications
Zealand Pharma
Email: akrassowska@zealandpharma.com